Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · IEX Real-Time Price · USD
393.98
+1.17 (0.30%)
May 1, 2024, 9:48 AM EDT - Market open
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
26
Consensus Rating
Buy
Price Target
$430.82
Upside
+9.35%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $445 → $450 | Strong Buy | Maintains | $445 → $450 | +14.22% | Apr 18, 2024 |
| UBS | UBS | Strong Buy Maintains $498 → $466 | Strong Buy | Maintains | $498 → $466 | +18.28% | Apr 17, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $500 | Buy | Maintains | $500 | +26.91% | Apr 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Sell Maintains $371 | Strong Sell | Maintains | $371 | -5.83% | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $457 → $462 | Strong Buy | Maintains | $457 → $462 | +17.27% | Apr 11, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold → Buy Upgrades $438 | Hold → Buy | Upgrades | $438 | +11.17% | Apr 11, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $440 | Buy | Reiterates | $440 | +11.68% | Feb 20, 2024 |
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $440 | Buy | Reiterates | $440 | +11.68% | Feb 6, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $438 → $450 | Buy | Maintains | $438 → $450 | +14.22% | Feb 6, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $500 → $540 | Buy | Maintains | $500 → $540 | +37.06% | Feb 6, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $397 → $420 | Hold | Maintains | $397 → $420 | +6.61% | Feb 6, 2024 |
| Barclays | Barclays | Buy Maintains $446 → $472 | Buy | Maintains | $446 → $472 | +19.80% | Feb 6, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $436 → $438 | Buy → Hold | Downgrades | $436 → $438 | +11.17% | Feb 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $397 → $457 | Strong Buy | Maintains | $397 → $457 | +16.00% | Feb 6, 2024 |
| Bernstein | Bernstein | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 2, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $390 → $438 | Buy | Maintains | $390 → $438 | +11.17% | Feb 1, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $456 → $508 | Strong Buy | Maintains | $456 → $508 | +28.94% | Jan 31, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $442 → $559 | Strong Buy | Maintains | $442 → $559 | +41.89% | Jan 31, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 31, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $415 → $440 | Buy | Maintains | $415 → $440 | +11.68% | Jan 24, 2024 |